HILLARY DAVIS: Open Payments
NPI 1285362913 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,701 in 136 payments from 31 companies in 2025. Trend: 2023 $1,077 · 2024 $2,419 · 2025 $2,701
Food & beverage: $2,423Education: $278
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $450 |
| Novartis Pharmaceuticals Corporation | 20 | $268 |
| Daiichi Sankyo Inc. | 10 | $218 |
| Incyte Corporation | 6 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $133 |
| Merck Sharp & Dohme LLC | 6 | $123 |
| PFIZER INC. | 7 | $116 |
| SEAGEN INC. | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 6 | $98 |
| Iovance Biotherapeutics, Inc. | 4 | $96 |
Products named: Enhertu, ERLEADA, KEYTRUDA, IBRANCE, Amtagvi, CABOMETYX, Fabhalta, LIBTAYO.
Industry payments across AR — which companies pay providers there.
